Atomistry » Iron » PDB 6nlk-6o6l » 6o3i
Atomistry »
  Iron »
    PDB 6nlk-6o6l »
      6o3i »

Iron in PDB 6o3i: Crystal Structure of Human IDO1 Bound to Navoximod (Nlg-919)

Enzymatic activity of Crystal Structure of Human IDO1 Bound to Navoximod (Nlg-919)

All present enzymatic activity of Crystal Structure of Human IDO1 Bound to Navoximod (Nlg-919):
1.13.11.52;

Protein crystallography data

The structure of Crystal Structure of Human IDO1 Bound to Navoximod (Nlg-919), PDB code: 6o3i was solved by S.F.Harris, A.Oh, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 74.17 / 2.69
Space group P 21 21 21
Cell size a, b, c (Å), α, β, γ (°) 85.062, 90.224, 130.237, 90.00, 90.00, 90.00
R / Rfree (%) 21.6 / 26.4

Other elements in 6o3i:

The structure of Crystal Structure of Human IDO1 Bound to Navoximod (Nlg-919) also contains other interesting chemical elements:

Fluorine (F) 2 atoms

Iron Binding Sites:

The binding sites of Iron atom in the Crystal Structure of Human IDO1 Bound to Navoximod (Nlg-919) (pdb code 6o3i). This binding sites where shown within 5.0 Angstroms radius around Iron atom.
In total 2 binding sites of Iron where determined in the Crystal Structure of Human IDO1 Bound to Navoximod (Nlg-919), PDB code: 6o3i:
Jump to Iron binding site number: 1; 2;

Iron binding site 1 out of 2 in 6o3i

Go back to Iron Binding Sites List in 6o3i
Iron binding site 1 out of 2 in the Crystal Structure of Human IDO1 Bound to Navoximod (Nlg-919)


Mono view


Stereo pair view

A full contact list of Iron with other atoms in the Fe binding site number 1 of Crystal Structure of Human IDO1 Bound to Navoximod (Nlg-919) within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Fe501

b:49.7
occ:1.00
FE A:HEM501 0.0 49.7 1.0
ND A:HEM501 2.0 49.8 1.0
NC A:HEM501 2.0 49.5 1.0
NB A:HEM501 2.0 49.3 1.0
NA A:HEM501 2.0 49.9 1.0
NE2 A:HIS346 2.1 48.9 1.0
N10 A:LKP502 2.1 47.4 1.0
C1D A:HEM501 2.9 50.1 1.0
C4D A:HEM501 3.0 50.0 1.0
C9 A:LKP502 3.0 47.5 1.0
C4B A:HEM501 3.0 49.6 1.0
C4C A:HEM501 3.0 49.8 1.0
C1B A:HEM501 3.0 49.7 1.0
CE1 A:HIS346 3.0 48.9 1.0
C1C A:HEM501 3.0 49.4 1.0
C4A A:HEM501 3.0 49.8 1.0
C1A A:HEM501 3.1 50.1 1.0
CD2 A:HIS346 3.1 49.5 1.0
C11 A:LKP502 3.3 48.4 1.0
CHD A:HEM501 3.3 50.5 1.0
CHA A:HEM501 3.4 50.5 1.0
CHC A:HEM501 3.4 50.2 1.0
CHB A:HEM501 3.4 50.2 1.0
ND1 A:HIS346 4.2 50.3 1.0
CG A:HIS346 4.2 49.3 1.0
C3D A:HEM501 4.2 50.7 1.0
C2D A:HEM501 4.2 50.4 1.0
C2C A:HEM501 4.2 50.0 1.0
C3C A:HEM501 4.2 50.1 1.0
N8 A:LKP502 4.2 46.1 1.0
C2A A:HEM501 4.3 50.6 1.0
C3A A:HEM501 4.3 50.4 1.0
C2B A:HEM501 4.3 49.8 1.0
C3B A:HEM501 4.3 50.0 1.0
C7 A:LKP502 4.4 47.5 1.0
CB A:ALA264 4.5 48.0 1.0

Iron binding site 2 out of 2 in 6o3i

Go back to Iron Binding Sites List in 6o3i
Iron binding site 2 out of 2 in the Crystal Structure of Human IDO1 Bound to Navoximod (Nlg-919)


Mono view


Stereo pair view

A full contact list of Iron with other atoms in the Fe binding site number 2 of Crystal Structure of Human IDO1 Bound to Navoximod (Nlg-919) within 5.0Å range:
probe atom residue distance (Å) B Occ
B:Fe501

b:56.4
occ:1.00
FE B:HEM501 0.0 56.4 1.0
NA B:HEM501 1.9 56.6 1.0
N10 B:LKP502 1.9 45.5 1.0
NC B:HEM501 2.0 56.3 1.0
ND B:HEM501 2.0 56.5 1.0
NB B:HEM501 2.0 56.2 1.0
NE2 B:HIS346 2.2 61.7 1.0
C9 B:LKP502 2.8 45.2 1.0
C4A B:HEM501 3.0 56.6 1.0
C1D B:HEM501 3.0 56.8 1.0
C4D B:HEM501 3.0 56.8 1.0
C4C B:HEM501 3.0 56.5 1.0
C1C B:HEM501 3.0 56.2 1.0
C1A B:HEM501 3.0 56.8 1.0
C1B B:HEM501 3.0 56.6 1.0
C4B B:HEM501 3.1 56.5 1.0
C11 B:LKP502 3.1 45.5 1.0
CE1 B:HIS346 3.1 61.5 1.0
CD2 B:HIS346 3.3 61.9 1.0
CHB B:HEM501 3.4 57.0 1.0
CHA B:HEM501 3.4 57.2 1.0
CHD B:HEM501 3.4 57.2 1.0
CHC B:HEM501 3.4 56.9 1.0
N8 B:LKP502 4.1 46.2 1.0
C7 B:LKP502 4.2 46.1 1.0
C3A B:HEM501 4.2 57.1 1.0
C2A B:HEM501 4.2 57.2 1.0
C2C B:HEM501 4.2 56.8 1.0
C3C B:HEM501 4.2 56.8 1.0
CB B:ALA264 4.3 53.3 1.0
C3D B:HEM501 4.3 57.2 1.0
ND1 B:HIS346 4.3 62.5 1.0
C2D B:HEM501 4.3 57.2 1.0
C2B B:HEM501 4.3 56.7 1.0
C3B B:HEM501 4.3 57.0 1.0
CG B:HIS346 4.4 60.9 1.0

Reference:

S.Kumar, J.P.Waldo, F.A.Jaipuri, A.Marcinowicz, C.Van Allen, J.Adams, T.Kesharwani, X.Zhang, R.Metz, A.J.Oh, S.F.Harris, M.R.Mautino. Discovery of Clinical Candidate (1R,4R)-4-((R)-2-((S)-6-Fluoro-5H-Imidazo[5, 1-A]Isoindol-5-Yl)-1-Hydroxyethyl)Cyclohexan-1-Ol (Navoximod), A Potent and Selective Inhibitor of Indoleamine 2,3-Dioxygenase 1. J.Med.Chem. V. 62 6705 2019.
ISSN: ISSN 0022-2623
PubMed: 31264862
DOI: 10.1021/ACS.JMEDCHEM.9B00662
Page generated: Wed Aug 7 04:04:52 2024

Last articles

Zn in 9JYW
Zn in 9IR4
Zn in 9IR3
Zn in 9GMX
Zn in 9GMW
Zn in 9JEJ
Zn in 9ERF
Zn in 9ERE
Zn in 9EGV
Zn in 9EGW
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy